edoxaban
Daiichi Sankyo
['cardio']
 presents envisage-tavi af trial at #esccongress.
predictors of long term mortaltiy following successful #tavr include mainly age, renal function and nonparoxysmal #atrialfibrillation #epeeps #cardiotwitter 
MD | PhD | Associate Professor of Cardiology | Interventional Cardiologist | Tel Aviv University | Sheba Medical Center | @MayoClinicCV trained